[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367973-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367973-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","decoding-intratumoral-cyclooxygenase-2-signaling-through-multi-omics-insights-from-esophageal-cancer-and-beyond","Decoding intratumoral cyclooxygenase-2 signaling through multi-omics: insights from esophageal cancer and beyond","","Cyclooxygenase-2 (COX-2), a prostaglandin-synthesis enzyme, is markedly upregulated across cancers, including esophageal cancer (ESCA). The study uses multi-omics and experimental validation (single-cell RNA sequencing, spatial transcriptomics, protein docking) to define COX-2’s role in tumor progression. COX-2 expression is elevated in ESCA and other malignancies, associates with malignant traits and worse prognosis, and activates oncogenic pathways such as TNF/NF-κB and IL-17. COX-2 also shapes a pro-inflammatory microenvironment by enhancing immune infiltration, especially macrophages, monocytes, and mast cells. Celecoxib reduces ESCA proliferation, migration, and invasion dose-dependently, and pan-cancer analyses link COX-2 to poor outcomes. COX-2 is identified as a regulator of inflammatory microenvironment and cancer progression, supporting biomarker and therapeutic potential.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/decoding-intratumoral-cyclooxygenase-2-signaling-through-multi-omics-insights-from-esophageal-cancer-and-beyond/367973/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/decoding-intratumoral-cyclooxygenase-2-signaling-through-multi-omics-insights-from-esophageal-cancer-and-beyond/367973.png","ImageObject",300,407,{"name":42,"@type":43},"awa","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-16","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does COX-2 play in esophageal cancer progression according to the study?","Question",{"text":63,"@type":64},"COX-2 expression is elevated in ESCA and correlates with malignant phenotypes and poor prognosis. It promotes oncogenic signaling and reshapes the tumor microenvironment to support tumor growth and immune escape.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which multi-omics approaches were used to investigate COX-2 signaling?",{"text":68,"@type":64},"The study integrates single-cell RNA sequencing, spatial transcriptomics, protein docking analysis, and experimental validation. It also includes single-cell and spatial data from other cancer types for comparison.",{"name":70,"@type":61,"acceptedAnswer":71},"How does celecoxib affect ESCA cells and what does the pan-cancer analysis show?",{"text":72,"@type":64},"Celecoxib, a selective COX-2 inhibitor, reduces ESCA cell proliferation, migration, and invasion in a dose-dependent manner. Pan-cancer analysis shows COX-2 as a poor prognostic indicator across multiple cancers.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367973,1790813260,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},3985747858093,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Clinical and Experimental Medicine (2026) 26:8 [https://doi.org/10.1007/s10238-025-01919-1](https://doi.org/10.1007/s10238-025-01919-1)  \nDecoding intratumoral cyclooxygenase‑2 signaling  \nthrough multi‑omics: insights from esophageal cancer and beyond  \nXiao‑Yu Zhuang1 · Da‑Ming Xu2 · Jun‑Nan Chen1 · Xiao‑Yu Huang1 · Shao‑Ping Wu1 · Yong‑Fa Zhang1 · Xin‑Hua He3  \nReceived: 22 May 2025 / Accepted: 25 September 2025 © The Author(s) 2025  \nAbstract  \nCyclooxygenase-2 (COX-2), an enzyme involved in prostaglandin synthesis, was significantly upregulated in various cancers, including esophageal cancer (ESCA). This study investigated the role of COX-2 in cancer progression and its potential as a therapeutic target, utilizing multi-omics approaches, including single-cell RNA sequencing, spatial transcriptomics, protein docking analysis and experimental validation. We found that COX-2 expression was significantly elevated in ESCA and other cancers, correlating with malignant phenotype and poor prognosis. Enrichment analyses revealed that COX-2 was involved in key oncogenic signaling pathways, including TNF/NF-κB and IL-17, which promoted cell proliferation, migration, and invasion. Additionally, COX-2 facilitated a pro-inflammatory microenvironment by enhancing immune cell infiltration, particularly macrophages, monocytes, and mast cells. Functional assays demonstrated that celecoxib, a selective COX-2 inhibitor, effectively reduced ESCA cell proliferation, migration, and invasion in a dose-dependent manner. Pan-cancer analysis confirmed that COX-2 was a poor prognostic indicator across various cancers, highlighting its broader clinical relevance. This study underscored COX-2 as a critical regulator of inflammatory microenvironment and cancer progression in ESCA, supporting its potential as both a prognostic biomarker and therapeutic target. The use of COX-2 inhibitors, such as celecoxib, holds promise for improving patient outcomes in ESCA and other COX-2-associated cancers.  \nKeywords Cyclooxygenase-2 · Esophageal cancer · Inflammation · Microenvironment · Celecoxib  \nIntroduction  \nCyclooxygenase-2 (COX-2) is an essential enzyme belonging to the cyclooxygenase family, encoded by prostaglandinendoperoxide synthase 2 (PTGS2), and is primarily involved in the synthesis of prostaglandins [1] . Unlike its counterpart COX-1, COX-2 expression is typically low in normal tissues  \n* Yong-Fa Zhang [email10yfzhang1@stu.edu.cn](email10yfzhang1@stu.edu.cn)  \n* Xin-Hua He[hexh@stu.edu.cn](hexh@stu.edu.cn)  \n1 Department of Anesthesiology, Second Affiliated Hospital of Shantou University Medical College, Shantou 515041, People’s Republic of China  \n2 State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou 510060, People’s Republic of China  \n3 Department of Physiology, Shantou University Medical College, Shantou 515041, People’s Republic of China  \nbut is significantly upregulated in pathological conditions such as inflammation and cancer [2, 3] . Recent studies have increasingly highlighted the oncogenic role of COX-2 across various cancer types [4 , 5] . Overexpression of COX-2 is closely associated with the aggressive behaviors of these cancers, suggesting its substantial contribution to cancer malignancy [6] . COX-2 influences cancer progression through multiple signaling pathways, including promoting cell proliferation via the phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) pathway [7] and enhancing angiogenesis by upregulating vascular endothelial growth factor (VEGF) [8] . Moreover, cancer-associated inflammation has long been recognized as a crucial factor in tumor development, serving as a key hallmark of malignancy. In the tumor microenvironment (TME), inflammatory cells actively promote tumor cell survival, proliferation, and migration, thereby facilitating tumor progression and metastasis [9] . Given its central role in inflamm","cbCaisMITbe6Hfch","https://ap.wps.com/l/cbCaisMITbe6Hfch","pdf",19969416,18,"English","# Abstract\n# Introduction\n# Materials and methods\n## Data source","[{\"question\":\"What role does COX-2 play in esophageal cancer progression according to the study?\",\"answer\":\"COX-2 expression is elevated in ESCA and correlates with malignant phenotypes and poor prognosis. It promotes oncogenic signaling and reshapes the tumor microenvironment to support tumor growth and immune escape.\"},{\"question\":\"Which multi-omics approaches were used to investigate COX-2 signaling?\",\"answer\":\"The study integrates single-cell RNA sequencing, spatial transcriptomics, protein docking analysis, and experimental validation. It also includes single-cell and spatial data from other cancer types for comparison.\"},{\"question\":\"How does celecoxib affect ESCA cells and what does the pan-cancer analysis show?\",\"answer\":\"Celecoxib, a selective COX-2 inhibitor, reduces ESCA cell proliferation, migration, and invasion in a dose-dependent manner. Pan-cancer analysis shows COX-2 as a poor prognostic indicator across multiple cancers.\"}]","Decoding intratumoral cyclooxygenase-2 signaling through multi-omics: insights from esophageal cancer and beyond | PDF",1790174041,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9eb6ac606e2c523ab768cce221ab2441.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/79c58097bd74f1cd3a85faba1fc96d80.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d45c283c85d0e30dcb2ef59f5c5cfc9d.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/352066f3425f507b869f704fedca33ef.webp",980,1301]